Alzheimer's Disease and Dementia
Aducanumab, Lecanemab for Early AD: The Clinical Trials That Led to FDA Approval
- Galcanezumab Safe and Effective for Migraine, Improves Symptoms
- Baclofen Discontinuation Rates for MS Spasticity Indicate Need for Alternatives
- Limited Drug Exposure Data Halt Accelerated Approval Attempt for Donanemab
- Spouses of Patients With Cancer Face Increased Risk for Psychiatric Disorders
- Adolescent Sleep Patterns Tied to Later Multiple Sclerosis Risk
- Healthy Lifestyle Lowers Memory Decline, Even for Those With Genetic Risk
- ACP Creates Living Guideline for Interventions During Acute Phase of Major Depression
- Emergency Department Screening Program Can ID Undiagnosed Prediabetes, T2DM
- Cluster Headache More Likely to Be Severe, Debilitating for Women Than Men
- Current, Former Smokers With MS Likely to Experience Depression and Anxiety
- Antibody Oligonucleotide Conjugate Fast Tracked for Facioscapulohumeral Muscular Dystrophy
- Moderna’s mRNA Vaccine Candidate Prevents RSV-Associated Disease in Older Adults
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
Wegovy Gains Approval for Treating Obesity in Adolescents
Visual Impairment Prevalent Among Women Living in Homeless Shelters
Paclitaxel-Eluting Stent for Treating Symptomatic Femoropopliteal PAD
Sulbactam-Durlobactam Gets Priority Review for Acinetobacter Infections
Lifestyle Modification Program Had Similar Outcomes as Mindfulness, Placebo in Treatment-Resistant Depression
